Board of Directors
Washington Biotechnology & Biomedical Association Announces New 2015 Board Members and Ex-Officio Members | Press Release
The WBBA’s Board of Directors is comprised of knowledgeable and experienced professionals from the life sciences sector in Washington state. The Board of Directors actively oversees our policies and strategy.
Composed of members of the Board, the Executive Committee is charged with monthly review of our financial performance and WBBA strategic directions
2015 Executive Committee
Board of Directors
- Chair – John Wecker, PhD, President & Chief Executive Officer | Pacific Northwest Diabetes Research Institute
- Treasurer – Margaret McCormick, PhD, Chief Executive Officer | Matrix Genetics
- Chris E. Rivera, President & Chief Executive Officer | Washington Biotechnology & Biomedical Association
- Thomas Clement, Chief Executive Officer | Aqueduct Critical Care
- Stephen M. Graham, Partner | Fenwick & West LLP
- Thong Q. Le, Chief Executive Officer | Accelerator Corporation
- Erik Nilsson, GAC Chairman, President | Insilicos
- Gregory Sessler, President & Chief Executive Officer | Spiration, Inc. d/b/a Olympus Respiratory America
- Martin Simonetti, President | VLST Corporation
- Todd Simpson, Chief Financial Officer | Seattle Genetics, Inc.
- Terrence J. Sweeney, Vice President Global Clinical Affairs | Philips Ultrasound
- Henrik Andersen, Executive Director, Bio-Process Development | ZymoGenetics, a Bristol Meyers Squibb Company
- Hovan Asdourian (Ex Officio), Life Sciences & Global Health Business Development Manager | Washington State Department of Commerce
- Kevin Baldwin, Pacific Northwest Market Managing Partner | Pricewaterhouse Coopers
- Charles V. Baltic III, Managing Director, Co-Head of Life Sciences | Needham & Company, LLC
- Norman J. Beauchamp, Jr., MD, MHS, Professor and Chairman Department of Radiology, Professor Industrial Systems and Engineering | University of Washington School of Medicine
- Jan Beck, Vice President Site Head | Novo Nordisk
- Clarissa Bolante, Of Counsel | DLA Piper LLP
- Bill Brady, President | Brady & Company
- Caitlin Cameron, Chief Executive Officer | OtoNexus Medical Technologies
- Lisa Cohen, Executive Director | Washington Global Health Alliance
- Rob Coopedge, Senior Vice President Strategic Investment & Corporate Development | Cambia Health Solutions
- John Cox, Senior Vice President, Seattle | Alexandria Real Estate Equities, Inc.
- Ralph Derrickson, Chief Executive Officer | Carena
- Helga Ding, DDS, MBA, MHA, Managing Director | Group Health Research Institute
- Sonya F. Erickson, Partner | Cooley LLP
- Alan D. Frazier (Ex Officio), Founder & Managing Partner | Frazier Healthcare Ventures
- Tom Fritz (Ex Officio), Chief Executive Officer | Inland Northwest Health Services
- Brad Gray, President & Chief Executive Officer | NanoStringTechnologies, Inc.
- Douglas R. Hansmann, PhD (Ex Officio)
- James B. Hendricks, PhD, President | Seattle Children’s Research Institute
- Lee Huntsman (Ex Officio), PhD, Board Member | Revalesio
- Erik Iverson, President, Business and Operations | IDRI
- Gabe Jones, (Ex Officio) Student, UW Foster Biotech Club | University of Washington
- Colleen Kerr, Chief Legislative Officer & AVP for External Affairs | Washington State University
- Jary J. Krauser, Chief Executive Officer | StratusG Consulting
- Homer Lane, Executive Director & CFO, Benaroya Research Insititute at Virginia Mason (BRI) | Vice President Research | Virginia Mason Medical Center (VMMC)
- Oren Lang-Furr, Partner Assurance | Ernst & Young LLP
- Jim Lisbakken, Partner and Chair of Life Sciences Practice Group | Perkins Coie LLP
- David Lowrance, CPA, Chief Financial Officer | Acucela Inc.
- Gustavo Mahler, PhD, Global Chief Operations Officer | CMC Biologics
- Tim Martin, Director of Global Government Affairs | Amgen
- Brian Mogen, (Ex Officio), President | Science & Engineering Business Association (SEBA)
- Ron Meyers, MS, JD, Chief Legal Officer & Vice President of Strategic Partnerships | Institute for Systems Biology
- Jonathan Norris, Managing Director, Life Sciences | Silicon Valley Bank
- Robert W. Overell, PhD, President & Chief Executive Officer | PhaseRx, Inc.
- H. Stewart Parker, Chief Executive Officer | IDRI
- David Poston, Chief Operating Officer | Allen Institute for Brain Science
- Jens U. Quistgaard, PhD, Chairman | Mirabilis Medica
- Rhonda Rhyne, President & Chief Executive Officer | Prevencio, Inc.
- Randy Schatzman, Chief Executive Officer | Alder BioPharmaceuticals, Inc.
- Andrew T. Serafini, PhD, Partner | Kilpatrick Townsend & Stockton LLP
- Lisa G. Shaffer, PhD, FACMG, Chief Executive Officer | Paw Print Genetics, a division of Genetic Veterinary Sciences, Inc.
- David Stafford, Chief Financial Officer | Physio-Control, Inc.
- Ken Stuart, PhD, Professor and Founder | Center for Infectious Disease Research
- Matt Stupfel, General Manager | EKOS Corporation
- Ronald Thomas, Commercialization Manager | Pacific Northwest National Laboratory- Battelle
- Francisco R. Velázquez, MD, SM, President and Chief Executive Officer | PAML LLC and PAML Ventures